Participated · Series D · Jul 2026

Fireworks AI is described as a startup focused on AI infrastructure solutions. The company recently completed a $1.5 billion funding round that values it at $17.5 billion, indicating strong investor interest and a significant jump in its financial profile. The round was led by Atreides Management, Index Ventures, and TCV, with contributions from NVIDIA, Evantic, and Lightspeed Venture Partners. Public reporting frames the raise as part of growing investor confidence in AI infrastructure. The articles do not provide details on specific products, revenue, users, founding year, location, or operational metrics.

Participated · Series F · May 2025

Airwallex offers an AI-native financial operating system and a suite of regulated financial infrastructure products, including payment acceptance, billing, global accounts, corporate cards, and spend management. The company holds 85+ licenses across North America, Europe, the Middle East, and Asia-Pacific and serves more than 676,000 businesses worldwide, directly or through platform partners. Airwallex reported $1.3 billion in annualized revenue and $287 billion in annualized transaction volume as of March 2026, with more than 90% of revenue coming from customers using multiple products. It is rolling out two new initiatives—T:0, an end-to-end AI-native finance platform currently in private beta, and Airi, a consumer wallet and agentic commerce infrastructure. The company plans to use recent funding to accelerate product development, expand its regulatory and infrastructure footprint, and scale teams to build next-generation AI-native financial software. Airwallex was founded in Melbourne in 2015 and is co-headquartered in San Francisco and Singapore, with over 2,300 employees across 27 offices.

Led · Series F · Dec 2021

Razorpay is a Bangalore-headquartered fintech that accepts, processes and disburses money for small businesses and enterprises. It operates a neobanking platform offering credit cards and working capital, an international payments gateway supporting over 90 currencies, and tools for tax and compliance disbursements, payment links, subscriptions, and automatic reconciliation. The company processes $60 billion in transactions annually (up from $5 billion in 2019) and serves over 8 million businesses, including Facebook, Swiggy, Cred, National Pension System and Indian Oil; 34 of the 42 startups that became unicorns in India this year use Razorpay. Razorpay has raised over $740 million over the past seven years and recently closed a $375 million Series F that brought in more capital than all its previous financings combined. The startup is expanding into Southeast Asia and plans to hire over 600 people to fuel growth and product expansion. Management says it will focus on merchant-focused financial services rather than consumer-focused neobanking and is preparing to be IPO-ready but won’t pursue public markets for at least two and a half years. Razorpay is a six-year-old, Bangalore-based fintech that accepts, processes and disburses money online and has expanded into neobanking, corporate credit cards and working capital for businesses. The Sequoia Capital India-backed startup was valued at $3 billion in an April financing round and became a unicorn a year ago. Razorpay has reported strong recent growth, citing 40–45% month-on-month expansion in recent months. The company says it is expanding beyond India and intends to build new products and deliver its payments and banking experience to businesses in Southeast Asia. Management views the new strategic investment from Salesforce Ventures as a way to further strengthen its presence in the business banking space. Razorpay is currently in the market to raise a new financing round and is negotiating a considerably larger valuation bump, according to a person familiar with the matter. Razorpay is a Bangalore-based fintech that accepts, processes and disburses money online for small businesses and enterprises and has expanded into neobanking and lending. Its core payments product is the market leader in India and the company also offers Razorpay X (corporate cards and neobanking) and Razorpay Capital (short-term business loans). More than 5 million businesses use Razorpay; Razorpay X serves about 15,000 businesses and Razorpay Capital is disbursing roughly $80 million annually, with typical loan tickets of 0.8–1 million INR for three- to six-month terms. The payments business grew 40–50% month-on-month over the prior six months and the company aims to process over $50 billion in total payment volume by the end of 2021. Razorpay has over 600 open positions and plans to use the new capital to accelerate Southeast Asia expansion and to pursue M&A opportunities to speed growth. Razorpay’s core product is an online payments processing platform that accepts a wide range of payment options (cards, mobile wallets, UPI) and disburses funds for businesses. In recent years it has expanded into lending and launched a neo-banking platform that issues corporate credit cards and other banking services. The company expects to process about $25 billion in transactions for nearly 10 million customers this year, a fivefold increase from last year. Razorpay says its neo-banking and capital arms (RazorpayX and Razorpay Capital) are expected to account for ~35% of revenue by the end of March next year. Management plans to deploy new capital to expand neo-banking features such as vendor payments, expense and tax management, and may pursue acquisitions to grow that category. Razorpay positions itself as the largest payments provider for business in India and competes with players such as PayU. Razorpay operates a payment gateway and expanded payments suite (Razorpay X) and runs a lending arm (Razorpay Capital). The company serves 350,000 merchants and, as of June, supported digital payments in 100 currencies; notable clients include Airtel, IRCTC, Zomato, and Swiggy. Razorpay X is in beta with about 1,500 merchants signed up and is expected to go live in roughly three months. Razorpay Capital has an annual disbursal run-rate of $100 million. The company plans to double down on non-gateway business lines, aiming for those to contribute an estimated 40% of overall revenue over the next two years. Razorpay is also planning to ramp headcount from about 350 to roughly 700 by the end of the fiscal year and pursue potential acquisitions.

Participated · Series F · Dec 2021

Cockroach Labs builds CockroachDB, a distributed SQL database with self-hosted and hosted (cloud/SaaS) offerings. The company also launched a serverless product in October in beta and plans to expand its product family. Its cloud business grew 500% over the last year and ARR tripled year-over-year from Q3 to Q3; the company reports 200 paying customers. While the majority of revenue still comes from the self-hosted version, management expects the hosted offering to grow faster over time. Cockroach partners with Amazon and Google on cloud installs and plans to support Microsoft Azure in 2022. Leadership has hired a CFO, views the company as positioned for a potential IPO, and says the new funding provides roughly 3–4 years of runway. Cockroach Labs builds CockroachDB, a cloud-native distributed SQL transactional database offering multi-cloud flexibility and data-locking for regulatory compliance. The product is used by organizations large and small across communications, gaming and entertainment, e-commerce and financial services. Customers named in the article include Equifax, Bose and Comcast. The company intends to use the new funding to expand operations, broaden its business reach and further develop the product. Cockroach Labs is NYC-based. As of this round the company has raised $355M in total funding and is valued at $2 billion. Cockroach Labs builds an open-source, scalable database with on-prem and cloud offerings, and launched its managed cloud service in 2018. The company uses its open-source product to attract users and convert a portion into paying customers. CEO and co-founder Spenser Kimball says the company has grown nearly 300% by number of customers. Cockroach competes with both traditional databases like Oracle and cloud providers such as Amazon. Financially the company has been raising substantial capital to support growth and weather economic uncertainty, most recently adding a large Series D. The team intends to continue hiring while being cautious and open to remote work adjustments. Cockroach Labs develops CockroachDB, a cloud-native distributed database engineered for resilience across nodes, data centers, and globally to provide local-like performance. The company offers a hosted cloud product on AWS while directly competing with AWS database services and traditional vendors such as Oracle. Cockroach changed its open-source licensing model, similar to MongoDB, to protect its commercial position against larger players. Management says Q1 revenue this year doubled all of last year, and indicated Q2 could double Q1, demonstrating rapid revenue growth. The company intends to accelerate sales momentum and continue product development to sustain that growth. Competing with much deeper-pocketed rivals, Cockroach emphasizes its global distribution capabilities as a key differentiator. Cockroach Labs develops CockroachDB, an open-source database service designed to replicate itself and maintain multi-active availability to minimize downtime. The product emphasizes resilient distributed replication so services remain available under failure scenarios. The company officially launched CockroachDB version 1.0 after a beta during which many (largely startup) customers adopted the service early. Cockroach is monetizing via a paid enterprise tier that adds distributed backup and restore functionality and enterprise support for serious users. Early customers include Baidu, which has tested the service processing two billion inserts a day while simulating extreme failure scenarios. The team plans a 1.1 release in five months, moving thereafter to a six-month release cadence, and is developing geo-partitioning for column-level geographic replication to reduce latency and aid data sovereignty.

Participated · Series F · Nov 2021

Benchling provides an R&D Cloud software platform that powers the biotechnology industry. Led by CEO Sajith Wickramasekara, the company says more than 200,000 scientists at over 600 companies and 7,000 research institutions globally use its platform. Since its Series E in April the company has introduced new capabilities, including support for Early Development and RNA therapeutics. Benchling recently hired Salesforce executive Lindsey Irvine as chief marketing officer. The company will use the funding to continue investing in product development and global expansion, with particular emphasis on its EMEA presence. In its first year in EMEA Benchling reached over 90 European customers, including Cutiss AG, Sanofi, Selexis SA and Syngenta, and grew its European team to more than 60 people. Benchling offers a life sciences R&D cloud platform used to design DNA, collaborate on experiments, automate data capture, manage research workflows and organize complex experimental datasets. Since launching in 2012, more than 300,000 scientists and 1,000 R&D organizations have adopted the platform. Customers include Gilead Sciences, Sanofi, Regeneron, Corteva Agrisciences and Sana Biotechnology. The company says it doubled its annual recurring revenue for the fourth year in a row while adding more than 150 customers across industries. Benchling has opened an EMEA headquarters in Zurich and plans to invest in product development and global expansion to support enterprise customers and biotech hubs. Benchling provides a unified R&D cloud platform powering the life science industry, with products including Notebook, Molecular Biology, Registry, Inventory, Request & Workflow Management, and Insights. The platform centralizes complex experimental datasets and optimizes R&D processes for multinational pharmaceutical corporations, emerging biotechnology companies, and research institutions. Since launching in 2012, more than 230,000 scientists and over 1,000 R&D organizations have adopted Benchling. Led by founder and CEO Saji Wickramasekara, the company intends to use new capital to build advanced product capabilities, expand its international presence, and drive broader adoption across leading R&D organizations. Benchling closed a $50M Series D to support these initiatives. Benchling is a cloud-based life sciences R&D platform that enables scientists to design DNA, collaborate on experiments, manage research workflows and make critical R&D decisions. Its solution features Notebook, Molecular Biology, Registry, Inventory, and Request & Workflow Management tools. The platform is used by over 170,000 scientists globally across multinational pharmaceutical corporations, emerging biotechnology companies, and major research institutions. Customers include academic labs at Harvard, MIT, Stanford, and Berkeley, as well as Zoetis, Beam Therapeutics, Zymergen and Regeneron Pharmaceuticals. Led by CEO Sajith Wickramasekara, the company will use the Series C funds to grow globally, extend its product lead and expand commercial relationships. Benchling is based in San Francisco, CA. Benchling offers a unified, cloud-based R&D informatics platform purpose-built for biologics, with applications including Lab Notebook, Molecular Biology, Bioregistration, Sample Tracking, and Request & Workflow Management. The platform is used by more than 100,000 scientists across enterprise and academic labs and has been adopted by customers such as Regeneron, Incyte, Editas Medicine, Agenus, Zymergen, and Obsidian Therapeutics. Since its last funding round in 2016, Benchling reports its ARR has grown 500% and its customer base has tripled year-over-year; customers report up to a 4x increase in productivity and up to a 67% reduction in emails. Benchling says it accelerates collaboration and knowledge retention for R&D teams, addressing reliance on paper notebooks and legacy systems. With the new funding, the company plans to accelerate product development, continue hiring (recent additions include Kaiser Mulla-Feroze as CMO and Sam Partovi for sales), and expand its enterprise and research-lab customer base. The company highlights use at major research institutions such as Harvard, MIT, UC Berkeley, and Stanford.